Medical literature grows at an overwhelming pace — over 2.5 million new biomedical papers are published every year. Pharma researchers need instant, accurate answers from this vast knowledge base while protecting highly sensitive proprietary data and meeting strict EU AI Act and data residency requirements. Leading Swiss life sciences companies are now deploying sovereign Retrieval-Augmented Generation (RAG) systems that securely query both public medical literature and internal research data without ever sending sensitive queries to foreign cloud providers — delivering faster insights while keeping every piece of data on Swiss infrastructure.
- Instant, accurate answers from millions of medical papers and internal documents
- Full data residency and EU AI Act compliance by design on Exoscale SKS
- Sovereign RAG eliminates the privacy risks of public AI tools
- Research teams accelerate literature reviews by 3–5×
- Complete auditability and explainability for every retrieved insight
The Limitations of Traditional Literature Search and Public RAG
Researchers still spend countless hours manually searching PubMed, Google Scholar, or internal databases. Public RAG tools promise speed but send sensitive queries and proprietary data to foreign hyperscalers — creating unacceptable privacy and compliance risks under the EU AI Act.
The Sovereign RAG Advantage for Swiss Pharma
Sovereign RAG systems combine the power of large language models with a private, vectorised knowledge base that lives entirely inside dedicated Swiss tenants on Exoscale SKS. Researchers can ask complex questions in natural language and receive precise, cited answers from both public medical literature and internal confidential documents.
How Sovereign RAG Works in Practice
The architecture uses a secure multi-stage pipeline:
• Secure Ingestion & Vectorisation Agent – processes and embeds millions of papers and internal documents
• Query Routing & Privacy Agent – ensures no sensitive data leaves Swiss borders
• Retrieval Agent – finds the most relevant chunks using sovereign vector search
• Generation & Citation Agent – produces accurate answers with full source citations and regulatory traceability
Everything runs with LangSmith audit trails and zero exposure to foreign jurisdictions.
Proven Results from Swiss Life Sciences Companies
Early deployments have delivered transformative outcomes:
• Literature review time reduced by 3–5×
• Higher-quality research insights with traceable sources
• Full EU AI Act compliance achieved automatically
• Elimination of data leakage risks associated with public AI tools
• Significant acceleration of drug discovery and clinical research timelines
Why Sovereignty Is Non-Negotiable for Medical RAG
Medical and research data are among the most sensitive assets in the life sciences industry. Sovereign RAG platforms deliver the speed of modern AI while guaranteeing the privacy, compliance, and data residency that Swiss pharma companies must maintain.
